Atlas Trials

Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis

Clinical trial NCT04262167 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04262167
Sponsor
University of North Carolina, Chapel Hill
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung Disease
Start date
2020-10-22
Primary completion
2027-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.